T 1589/19 (Competing antibodies/IMMUNEX) of 10.03.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T158919.20220310
- Date of decision
- 10 March 2022
- Case number
- T 1589/19
- Petition for review of
- -
- Application number
- 15168899.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of interleukin-4 receptor antibodies and compositions thereof
- Applicant name
- Immunex Corporation
- Opponent name
- Regeneron Pharmaceuticals, Inc.
Sanofi - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 76(1)European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 012(1)(a)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Divisional application - subject-matter extends beyond content of earlier application
Divisional application - main request and auxiliary request 1 (yes)
Clarity - auxiliary requests 2 and 3 (no)
Basis of proceedings - decision under appeal - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.